Why Invest in Avocet?

Avocet Polymer Technologies was founded in 1996 and has since developed and commercialized leading products in the United States that are grounded in established pharmacology and proven drug delivery technologies. Headquartered in Chicago, Illinois, Avocet designs, manufactures, and markets innovative drugs, ointments, and devices for the treatment and management of scar conditions. With over 30 issued patents and several next-generation scar prevention and reduction therapies in development, Avocet continues to advance the science of skin healing through research-driven innovation.

Avocet Polymer Technologies develops advanced scar treatment products that combine pharmaceutical science with innovative polymer engineering to improve upon conventional therapies available in the market today.

Avocet currently has two flagship products: Avogel and Avosil.

• Avogel is a hydrogel-based therapy that uses water as an active therapeutic component to enhance the skin’s healing environment. By increasing both hydration and temperature within the scar tissue, Avogel promotes optimal conditions that help minimize scar formation while relieving pain, itching, and tenderness. Its non-occlusive formulation softens and smooths scar tissue over time and is recommended by medical professionals for use following surgery, burns, and trauma.

• Avosil is a topical ointment designed to manage inflamed or hypertrophic scars, particularly those that are itchy, irritated, or uncomfortable during the healing process. It delivers anti-inflammatory and soothing agents within a biocompatible polymer base that supports the natural healing of damaged skin while reducing redness and irritation. Avosil complements Avogel by providing targeted relief during the early stages of recovery.

Together, these products position Avocet as a leader in comprehensive scar management, from prevention to long-term improvement.

Avocet maintains a robust intellectual property portfolio with over 30 issued patents and several new formulations in development, including next-generation scar prevention and reduction therapies. This strong foundation of innovation and clinically driven design highlights Avocet’s continued potential for growth and market expansion.

Because of their proven effectiveness, Avogel and Avosil are distributed nationwide through leading pharmaceutical channels. Both products are available via dropship through Cardinal Health and McKesson, and can be found at major retailers including CVS, Walgreens, Target, and Walmart. They are also conveniently available for purchase online at Amazon.com.